Radar > 400126

Substrate AI retains LKS Next to launch IPO for 4D Médica

Substrate AI encarga a LKS Next la salida a bolsa de 4D Médica

Intel ID : 400126

Relevant Documents

Issuer

Ultimate Owner (Issuer)

Substrate AI Spain
Spain

Advisors

retained

Intel ID 400126
Value EUR 21,50m (Approx.)
Native Currency Euro (EUR)
Financial Data - Substrate AI Spain
(31 Dec 2023)
Revenue: EUR 0,12m
EBITDA: EUR 0,01m
Date
Country
Geography
Subsector (Old TTR Sectors)
Primary Subsector (TTRSC)
40.03.07 IT Consulting, Development & Outsourcing (Primary)
40 Information Technology / 40.03 Internet, Software & IT Services

30.02.04 Medical Diagnostic Equipment (Primary)
30 Healthcare / 30.02 Healthcare Equipment & Supplies

Secondary Subsectors (TTRSC)
40.02.99 Other Industry-Specific Software
40 Information Technology / 40.02 Industry-Specific Software

Type
Intel Grade
Source
Tags

Issuer

Name
verified
Subsector (Old TTR Sectors)
Services and Distribution / Healthcare, Hygiene, Medical Aesthetics and Cosmetics (Primary)
Primary Sector (TTRSC)
30.02.04 Medical Diagnostic Equipment
30 Healthcare / 30.02 Healthcare Equipment & Supplies

Country
Website
Description

Ultimate Owner (Issuer)

Name
verified
Subsector (Old TTR Sectors)
Technology and Telecoms / Technology (Primary)
Primary Sector (TTRSC)
40.03.07 IT Consulting, Development & Outsourcing
40 Information Technology / 40.03 Internet, Software & IT Services

Secondary Sectors (TTRSC)
40.02.99 Other Industry-Specific Software
40 Information Technology / 40.02 Industry-Specific Software

Country
Website
Description

Financial Advisory

Radar

Date Title Type Intel Grade Country Subsector  

Legend:

verified Verified: Confirmed as a party to an active or possible transaction.

potential Potential: Unconfirmed as a party to an active or possible transaction.

retained Retained: Confirmed as “Retained” with a general or specific mandate.

prospect Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.

Transactional data is continuously updated by the research team and therefore is subject to change.